Evidence map›Paper›PMID 27496552›Full record

SynthesisJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2016

Cerebral blood flow in small vessel disease: A systematic review and meta-analysis.

Yulu Shi, Michael J Thrippleton, Stephen D Makin, Ian Marshall, Mirjam I Geerlings, Anton J M de Craen, Mark A van Buchem, Joanna M Wardlaw

Registry-linked trialAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06077305 (A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic Stroke, MODEST, Research Protocol), which is not on this map. Cited by 182 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
182citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06077305 not yet recruitingnot on this mapstarted 2023, after this paper: background citation

A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic Stroke, MODEST, Research Protocol

TypeobservationalSponsorBeijing Tiantan HospitalRan2023 to 2026Enrolled20,000ConditionsCerebral Small Vessel Diseases, Ischemic Stroke
3 · Its place in the literature

Who cites it

182 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Relationship between cerebral white matter hyperintensities and autonomic function in older individuals with cerebral small vessel disease.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026
    Article
  12. Cerebral perfusion features linking subclinical cardiac and aortic dysfunction to vascular brain injury.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  13. Review
  14. Roles of Microglia in Cerebral Small Vessel Disease.CNS neuroscience & therapeutics · 2026
    Review
  15. Article
  16. Midlife hypertension and late-life cognition: weighting the LifeAfter90 study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

122 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yulu ShiCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom Department of Neurology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Michael J ThrippletonCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Stephen D MakinCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Ian MarshallCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Mirjam I GeerlingsUniversity Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
Anton J M de CraenDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, Netherlands.
Mark A van BuchemDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands.
Joanna M WardlawCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom Joanna.Wardlaw@ed.ac.uk.

Funding

Chief Scientist Office ETM/326Medical Research CouncilWellcome Trust
6 · The paper itself

Abstract

White matter hyperintensities are frequent on neuroimaging of older people and are a key feature of cerebral small vessel disease. They are commonly attributed to chronic hypoperfusion, although whether low cerebral blood flow is cause or effect is unclear. We systematically reviewed studies that assessed cerebral blood flow in small vessel disease patients, performed meta-analysis and sensitivity analysis of potential confounders. Thirty-eight studies (n = 4006) met the inclusion criteria, including four longitudinal and 34 cross-sectional studies. Most cerebral blood flow data were from grey matter. Twenty-four cross-sectional studies (n = 1161) were meta-analysed, showing that cerebral blood flow was lower in subjects with more white matter hyperintensity, globally and in most grey and white matter regions (e.g. mean global cerebral blood flow: standardised mean difference-0.71, 95% CI -1.12, -0.30). These cerebral blood flow differences were attenuated by excluding studies in dementia or that lacked age-matching. Four longitudinal studies (n = 1079) gave differing results, e.g., more baseline white matter hyperintensity predated falling cerebral blood flow (3.9 years, n = 575); cerebral blood flow was low in regions that developed white matter hyperintensity (1.5 years, n = 40). Cerebral blood flow is lower in subjects with more white matter hyperintensity cross-sectionally, but evidence for falling cerebral blood flow predating increasing white matter hyperintensity is conflicting. Future studies should be longitudinal, obtain more white matter data, use better age-correction and stratify by clinical diagnosis.

Indexed as

AgingBlood Flow VelocityCerebral Small Vessel DiseasesCerebrovascular CirculationDementiaGray MatterHumansMagnetic Resonance AngiographyUltrasonography, DopplerWhite MatterCerebral blood flowcerebral small vessel diseasemeta-analysissystematic reviewwhite matter hyperintensities

Identifiers

PMID27496552
PMCPMC5076792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.